Android app on Google Play

Digirad (DRAD) Receives FDA 510(k) Clearance for nSPEED(R) Software

September 22, 2008 1:36 PM EDT Send to a Friend
Digirad Corporation (Nasdaq: DRAD) today announced it received from the U.S. FDA 510(k) clearance for its new nSPEED(R) reconstruction software -- for reduced imaging time and improved image quality with less radiation exposure for patients -- to be used in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and non-parallel hole collimators.

Digirad Corporation provides diagnostic nuclear and ultrasound imaging systems and services to physicians' offices, hospitals, imaging centers, and other medical services providers primarily in the United States.



You May Also Be Interested In


Related Categories

FDA

Add Your Comment